---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-001225"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2026-01-14T23:59:59+00:00"
generated_at: "2026-05-16T10:25:01.253693+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "medium"
source: SEC EDGAR
---

# Pulse Biosciences posts investor deck detailing progress on nPulse devices

## Summary
- Updated investor presentation highlights recent progress on nPulse Vybrance Percutaneous Electrode, Cardiac Clamp, and Cardiac Catheter.
- Presentation posted January 14, 2026; company expects to use it in investor meetings and analyst calls.
- Deck available on company website under Investors section; no financial or clinical data disclosed.

## SEC filing metadata
- accession: 0001437749-26-001225
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2026-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774926001225/0001437749-26-001225-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774926001225/plse20260113_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-001225
- JSON: https://secwatch.observer/filing/0001437749-26-001225.json
- Plain text: https://secwatch.observer/filing/0001437749-26-001225.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.